Efficacy of TachoSil, a Fibrin-Based Hemostat, for Anterior Lumbar Spine Surgery.
10.4184/asj.2016.10.5.930
- Author:
Jo WATANABE
1
;
Seiji OHTORI
;
Sumihisa ORITA
;
Kazuyo YAMAUCHI
;
Yawara EGUCHI
;
Yasuchika AOKI
;
Junichi NAKAMURA
;
Miyako SUZUKI
;
Kazuhide INAGE
;
Jun SATO
;
Yasuhiro SHIGA
;
Koki ABE
;
Kazuki FUJIMOTO
;
Hirohito KANAMOTO
;
Eiji HANAOKA
;
Kazuhisa TAKAHASHI
Author Information
1. Department of Orthopaedic Surgery, Graduate School of Medicine, Chiba University, Chiba, Japan. sohtori@faculty.chiba-u.jp
- Publication Type:Original Article
- Keywords:
TachoSil;
A fibrin-based hemostat;
Anterior lumbar fusion surgery;
Blood
- MeSH:
Aorta;
Arteries;
Blood Vessels;
Female;
Hemorrhage;
Hemostasis;
Humans;
Iliac Vein;
Retrospective Studies;
Spine*;
Spondylolisthesis;
Surgeons;
Sutures
- From:Asian Spine Journal
2016;10(5):930-934
- CountryRepublic of Korea
- Language:English
-
Abstract:
STUDY DESIGN: Retrospective case series. PURPOSE: To examine the efficacy of TachoSil for vessel injury in 6 patients who underwent anterior lumbar fusion surgery (ALF). OVERVIEW OF LITERATURE: ALF for the lumbar spine has a high rate of success, although intraoperative concerns and iatrogenic complications are known, and injury of a major vessel is sometimes a complication. The efficacy of TachoSil, a fibrin-based hemostat, has been reported for several types of surgery; however, use of TachoSil for ALF surgery has not been described. Here, we report on the efficacy of TachoSil in 6 patients, who underwent ALF after vascular surgeons having difficulty in repairing vessels. METHODS: Two man and 4 women with average age of 50.8±10.9 (mean±standard deviation) were diagnosed with a vertebral tumor (2 patients), L4 degenerative spondylolisthesis (2 patients), and L5 spondylolytic spondylolisthesis (2 patients) and underwent ALF. The blood vessels injured included the common iliac vein in 2 patients and a branch of a segmental artery from the aorta in 4 patients. We consulted a vascular surgeon to suture or repair the vessels during surgery, and although the vascular surgeon attempted to address the injuries, suturing or repair was not possible in these cases. For this reason, we used TachoSil to repair the injury in the vessels walls or to stop the bleeding. RESULTS: Time to pressure hemostasis using TachoSil was 34±12 minutes, and total blood loss was 1,488±1,711 mL. Nevertheless, all vessel injuries were controlled by the use of TachoSil. CONCLUSIONS: We recommend the use of TachoSil for vessel injuries that vascular surgeons cannot suture or repair during ALF surgery.
